Supernus Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Supernus Pharmaceuticals

05/11/2024 07:54

* Supernus Pharmaceuticals Inc  SUPN.OQ  reported quarterly
adjusted earnings of 69 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of 24 cents.  The mean expectation of
four analysts for the quarter was for earnings of 44 cents per
share. Wall Street expected results to range from 35 cents to 55
cents per share.
    * Revenue rose 14.2% to $175.69 million from a year ago;
analysts
expected $157.30 million. 
    * Supernus Pharmaceuticals Inc's reported EPS for the
quarter was
69 cents​.
    * The company reported quarterly net income of $38.5
million.
    * Supernus Pharmaceuticals Inc shares had risen by 11.3%
this
quarter and gained 19.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Supernus
Pharmaceuticals Inc is $39.00 
This summary was machine generated from LSEG data November 5 at
07:54 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.44           0.69           Beat
 Jun. 30 2024      0.39           0.36           Missed
 Mar. 31 2024      0.38           0.26           Missed
 Dec. 31 2023      0.55           0.89           Beat